# Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.

> **NCT00261391** · PHASE1 · COMPLETED · sponsor: **Boston Children's Hospital** · enrollment: 9 (—)

## Conditions studied

- Vascular Anomalies

## Interventions

- **DRUG:** Marimastat

## Key facts

- **NCT ID:** NCT00261391
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-10
- **Primary completion:** —
- **Final completion:** 2007-10
- **Target enrollment:** 9 (—)
- **Last updated:** 2008-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00261391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00261391, "Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00261391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*